Alginate microparticles for Polymyxin B Peyer's patches uptake: microparticles for antibiotic oral administration

G Coppi1, V Iannuccelli, N Sala

  • 1Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Via Campi, 183, 41100 Modena, Italy. coppi.gilberto@unimore.it

Insights

Novel microparticles enhance oral drug delivery by protecting Polymyxin B (PMB) in the gastrointestinal tract. This approach improves drug bioavailability for targeted delivery to the Gut Associated Limphoid Tissue (GALT).

Area of Science:

  • Pharmaceutics and Drug Delivery
  • Biomaterials Science
  • Microbiology

Background:

  • Oral administration of drugs like Polymyxin B (PMB) is often limited by poor bioavailability.
  • The Gut Associated Limphoid Tissue (GALT) is a key target for localized drug delivery within the intestine.
  • M cells in Peyer's patches offer a pathway for targeted uptake into the GALT.

Purpose of the Study:

  • To develop microparticles for improved oral delivery of Polymyxin B (PMB).
  • To enhance PMB's oral bioavailability by protecting it within the gastrointestinal tract.
  • To facilitate drug delivery to the Gut Associated Limphoid Tissue (GALT) via M cell uptake.

Main Methods:

  • Preparation of sub-3-micrometer alginate microparticles using spray-drying.
  • Cross-linking of microparticles with calcium ions and chitosan to ensure gastrointestinal resistance.
  • Evaluation of PMB loading, alginate/PMB interaction, cross-linking degree, and PMB activity using spectrophotometry, rheology, EDS, and microbiological assays.

Main Results:

  • Optimized cross-linking of alginate microparticles enabled effective loading and retention of cationic PMB in gastric conditions.
  • Sustained release of PMB was achieved in intestinal fluid.
  • The developed microparticle system preserved the biological activity of Polymyxin B.

Conclusions:

  • Sub-3-micrometer alginate-chitosan microparticles are a promising system for oral delivery of Polymyxin B.
  • This formulation enhances PMB's oral bioavailability and enables targeted delivery to the GALT.
  • The method ensures the preservation of the antibiotic's therapeutic efficacy.

Related Concept Videos

Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...